These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 465055)

  • 21. Antibodies to the nicotinic acetylcholine receptor, obtained from serum of myasthenic patients, may decrease acetylcholine release from rat hippocampal nerve endings in vitro.
    Heilbronn E; Häggblad J; Kubát B
    Ann N Y Acad Sci; 1981; 377():198-207. PubMed ID: 6951473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapsyn antibodies in myasthenia gravis.
    Agius MA; Zhu S; Kirvan CA; Schafer AL; Lin MY; Fairclough RH; Oger JJ; Aziz T; Aarli JA
    Ann N Y Acad Sci; 1998 May; 841():516-21. PubMed ID: 9668284
    [No Abstract]   [Full Text] [Related]  

  • 23. Regulatory action of Astragalus saponins and buzhong yiqi compound on synthesis of nicotinic acetylcholine receptor antibody in vitro for myasthenia gravis.
    Tu LH; Huang DR; Zhang RQ; Shen Q; Yu YY; Hong YF; Li GH
    Chin Med J (Engl); 1994 Apr; 107(4):300-3. PubMed ID: 8088200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T-helper lymphocytes in myasthenia gravis recognize the nicotinic receptor alpha subunit.
    Hohlfeld R; Toyka KV; Tzartos SJ; Carson W; Conti-Tronconi BM
    Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5379-83. PubMed ID: 2955417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of acetylcholine receptor antibody derived from myasthenia gravis on the rat central neuronal nicotinic acetylcholine receptor].
    Li Z; Ju G; Qiu X
    Zhonghua Nei Ke Za Zhi; 1997; 36(1):15-7. PubMed ID: 9812554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-acetylcholine receptor antibodies directed against the alpha-bungarotoxin binding site induce a unique form of experimental myasthenia.
    Gomez CM; Richman DP
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4089-93. PubMed ID: 6575398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor.
    Schwartz M; Novick D; Givol D; Fuchs S
    Nature; 1978 Jun; 273(5663):543-5. PubMed ID: 78451
    [No Abstract]   [Full Text] [Related]  

  • 29. Monoclonal antibodies used to probe acetylcholine receptor structure: localization of the main immunogenic region and detection of similarities between subunits.
    Tzartos SJ; Lindstrom JM
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):755-9. PubMed ID: 6153804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificities of antibodies to acetylcholine receptors.
    Lindstrom J; Campbell M; Nave B
    Muscle Nerve; 1978; 1(2):140-5. PubMed ID: 86951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal hybridoma anti-acetylcholine receptor antibodies: antibody specificity and effect of passive transfer.
    Gomez CM; Richman DP; Burres SA; Arnason BG; Berman PW; Fitch FW
    Ann N Y Acad Sci; 1981; 377():97-109. PubMed ID: 6978667
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 33. Linkage between the frequency of muscular weakness and loci that regulate immune responsiveness in murine experimental myasthenia gravis.
    Berman PW; Patrick J
    J Exp Med; 1980 Sep; 152(3):507-20. PubMed ID: 6774045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular immune response against acetylcholine receptor in myasthenia gravis: I. Relevance to clinical course and pathogenesis.
    Conti-Tronconi BM; Morgutti M; Sghirlanzoni A; Clementi F
    Neurology; 1979 Apr; 29(4):496-501. PubMed ID: 571548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
    Bogdan I; Crisanda V
    Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificities of antibody to acetylcholine receptor in rabbits with experimental myasthenia gravis.
    Ueno S; Kang J; Takeuchi H; Takahashi M; Tarui S
    Clin Exp Immunol; 1980 Jul; 41(1):13-8. PubMed ID: 6777100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hybridoma established from spleen cells of a rat immune to syngeneic bladder tumor: its secretion of monoclonal antibody specific for a tumor cell clone in a long-term transplanted bladder tumor line.
    Hashimoto Y; Masuko T
    Gan; 1981 Apr; 72(2):329-30. PubMed ID: 7286556
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal antibodies. A new technique for producing serologic reagents.
    Diamond BA; Yelton DE; Scharff MD
    N Engl J Med; 1981 May; 304(22):1344-9. PubMed ID: 6783911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.